Surmodics Inc (SRDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 22,676 | 22,241 | 23,038 | 22,227 | 19,058 |
| Cost of Goods | 3,093 | 3,523 | 4,089 | 4,104 | 2,913 |
| Gross Profit | 19,583 | 18,718 | 18,949 | 18,123 | 16,145 |
| Operating Expenses | 18,811 | 18,529 | 21,479 | 24,477 | 16,533 |
| Operating Income | 865 | 712 | -2,441 | -6,250 | 525 |
| Interest Expense | 37 | 37 | 0 | 0 | 0 |
| Other Income | 272 | 459 | 411 | 955 | -211 |
| Pre-tax Income | 1,100 | 1,134 | -2,030 | -5,295 | 314 |
| Income Tax | -162 | -176 | -277 | -2,613 | -1,220 |
| Net Income Continuous | 1,262 | 1,310 | -1,753 | -2,682 | 1,534 |
| Net Income | $1,262 | $1,310 | $-1,753 | $-2,682 | $1,534 |
| EPS Basic Total Ops | 0.09 | 0.10 | -0.14 | -0.20 | 0.12 |
| EPS Basic Continuous Ops | 0.09 | 0.10 | -0.13 | -0.20 | 0.12 |
| EPS Diluted Total Ops | 0.09 | 0.09 | -0.13 | -0.20 | 0.11 |
| EPS Diluted Continuous Ops | 0.09 | 0.09 | -0.13 | -0.20 | 0.11 |
| EBITDA(a) | $2,684 | $2,468 | $-721 | $-4,645 | $2,111 |